BANK OF AMERICA CORP /DE/ - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 37 filers reported holding LIANBIO in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of LIANBIO
ValueSharesWeighting
Q3 2023$17,652
-29.7%
11,847
+7.6%
0.00%
Q2 2023$25,103
+0.2%
11,010
-13.9%
0.00%
Q1 2023$25,055
+21.9%
12,783
+2.0%
0.00%
Q4 2022$20,552
+28.4%
12,532
+53.3%
0.00%
Q3 2022$16,000
+700.0%
8,177
+715.3%
0.00%
Q2 2022$2,0001,003
+1255.4%
0.00%
Q1 2022$0
-100.0%
74
-99.9%
0.00%
Q4 2021$519,00084,3560.00%
Other shareholders
LIANBIO shareholders Q4 2021
NameSharesValueWeighting ↓
Perceptive Advisors 112,639,920$693,862,0005.35%
Vida Ventures Advisors, LLC 2,282,084$14,058,0005.26%
VR Adviser, LLC 5,378,341$33,131,0004.53%
SCHF (GPE), LLC 937,500$5,775,0001.04%
RA Capital Management 7,655,015$47,155,0000.83%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$20,415,0000.61%
Logos Global Management LP 412,837$2,543,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,782,747$10,982,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 275,007$1,662,0000.18%
Affinity Asset Advisors, LLC 72,406$446,0000.16%
View complete list of LIANBIO shareholders